NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE

Product NDC: 44567-640
11-digit product format: 445670640
Labeler code: 44567
Product ID: 44567-640_2c00d1f5-dc7f-48a6-8347-5114a389b662
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: NOREPINEPHRINE BITARTRATE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: WG Critical Care, LLC
Application: NDA215700
Marketing category: NDA
Marketing start: 2022-09-15
Substance: NOREPINEPHRINE BITARTRATE
Active strength: .016 mg/mL
Pharmacologic classes: Catecholamine [EPC], Catecholamines [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	NOREPINEPHRINE BITARTRATE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15
N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	NOREPINEPHRINE BITARTRATE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15
N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	NOREPINEPHRINE BITARTRATE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15
N215700-004	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	NOREPINEPHRINE BITARTRATE	EQ 32MG BASE/250ML (EQ 128MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2025-10-15

Orange Book patents#

Current patent rows page 1 of 1 · 10 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Coverage / status	Submission date
N215700-001	RE49422	2035-02-26	Drug product	2025-03-03
N215700-001	10888534	2039-04-26	Drug product	2022-09-21
N215700-002	RE49422	2035-02-26	Drug product	2025-03-03
N215700-002	10888534	2039-04-26	Drug product	2022-09-21
N215700-003	RE49422	2035-02-26	Drug product	2025-03-03
N215700-003	RE49443	2035-02-26	Drug product	2025-03-03
N215700-003	10888534	2039-04-26	Drug product	2022-09-21
N215700-004	RE49422	2035-02-26	Drug product	2026-01-22
N215700-004	RE49443	2035-02-26	Drug product	2026-01-22
N215700-004	10888534	2039-04-26	Drug product	2026-01-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 89 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-004	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 32MG BASE/250ML (EQ 128MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2025-10-15	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-004	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 32MG BASE/250ML (EQ 128MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2025-10-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-004	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 32MG BASE/250ML (EQ 128MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2025-10-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-004	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 32MG BASE/250ML (EQ 128MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2025-10-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N215700-001	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N215700-002	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N215700-003	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2022-09-15	`d06236e962d9…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N215700-001	RE49422	2035-02-26	Drug product	2025-03-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-001	10888534	2039-04-26	Drug product	2022-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-002	RE49422	2035-02-26	Drug product	2025-03-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-002	10888534	2039-04-26	Drug product	2022-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-003	RE49422	2035-02-26	Drug product	2025-03-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-003	RE49443	2035-02-26	Drug product	2025-03-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-003	10888534	2039-04-26	Drug product	2022-09-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-004	RE49422	2035-02-26	Drug product	2026-01-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-004	RE49443	2035-02-26	Drug product	2026-01-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N215700-004	10888534	2039-04-26	Drug product	2026-01-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N215700-001	RE49422	2035-02-26	Drug product	2025-03-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-001	10888534	2039-04-26	Drug product	2022-09-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-002	RE49422	2035-02-26	Drug product	2025-03-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-002	10888534	2039-04-26	Drug product	2022-09-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-003	RE49422	2035-02-26	Drug product	2025-03-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-003	RE49443	2035-02-26	Drug product	2025-03-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-003	10888534	2039-04-26	Drug product	2022-09-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-004	RE49422	2035-02-26	Drug product	2026-01-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-004	RE49443	2035-02-26	Drug product	2026-01-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N215700-004	10888534	2039-04-26	Drug product	2026-01-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N215700-001	RE49422	2035-02-26	Drug product	2025-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-001	10888534	2039-04-26	Drug product	2022-09-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-002	RE49422	2035-02-26	Drug product	2025-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-002	10888534	2039-04-26	Drug product	2022-09-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-003	10251848	2035-02-26	Drug product	2025-03-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-003	RE49422	2035-02-26	Drug product	2025-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-003	RE49443	2035-02-26	Drug product	2025-03-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-003	10888534	2039-04-26	Drug product	2022-09-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-004	RE49422	2035-02-26	Drug product	2026-01-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-004	RE49443	2035-02-26	Drug product	2026-01-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N215700-004	10888534	2039-04-26	Drug product	2026-01-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-001	RE49422	2035-02-26	Drug product	2025-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-001	10888534	2039-04-26	Drug product	2022-09-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-002	RE49422	2035-02-26	Drug product	2025-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-002	10888534	2039-04-26	Drug product	2022-09-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-003	10251848	2035-02-26	Drug product	2025-03-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-003	RE49422	2035-02-26	Drug product	2025-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-003	RE49443	2035-02-26	Drug product	2025-03-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N215700-003	10888534	2039-04-26	Drug product	2022-09-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N215700-001	RE49422	2035-02-26	Drug product	2025-03-03	`6a471c1ec25d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NOREPINEPHRINE BITARTRATE	.016 mg/mL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
2ab36713-99a4-1d04-c42f-907afc73b6f9	Product name	7	20260105
209a4db0-2639-413d-9ad3-274ad7be11f7	Product name	1	20230912
08ddeef6-6d79-428b-a00b-432b50fc2b32	Product name	1	20230831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
44567-640-01	NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE	250 mL in 1 BAG	INJECTION, SOLUTION	250		10
44567-640-10	NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE	10 in 1 CARTON	INJECTION, SOLUTION	10		10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
44567-640-01	ML - Milliliter	44567-640	0d2045d8-a469-478c-a1a5-ae79d040afba	1	2023-04-07
44567-640-10	ML - Milliliter	44567-640	b3c0add3-0ab9-41cd-b971-0912584521ce	1	2023-04-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
44567-640	NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) INJECTION, SOLUTION [WG CRITICAL CARE, LLC]	7	Current NDC, Legacy NDC, 2 package rows	20240621_ddbef60d-c20a-4ada-928f-e87074c08a54.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
IFY5PE3ZRW	NOREPINEPHRINE BITARTRATE	108341-18-0	NOREPINEPHRINE BITARTRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2619579	norepinephrine bitartrate 16 MG in 250 ML Injection	PSN	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2725614	norepinephrine bitartrate 32 MG in 250 ML Injection	PSN	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475337	norepinephrine bitartrate 4 MG in 250 ML Injection	PSN	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475340	norepinephrine bitartrate 8 MG in 250 ML Injection	PSN	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475337	250 ML norepinephrine 0.016 MG/ML Injection	SCD	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475340	250 ML norepinephrine 0.032 MG/ML Injection	SCD	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2619579	250 ML norepinephrine 0.064 MG/ML Injection	SCD	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2725614	250 ML norepinephrine 0.128 MG/ML Injection	SCD	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2619579	norepinephrine (as bitartrate) 16 MG per 250 ML Injection	SY	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2725614	norepinephrine (as bitartrate) 32 MG per 250 ML Injection	SY	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475337	norepinephrine (as bitartrate) 4 MG per 250 ML Injection	SY	ddbef60d-c20a-4ada-928f-e87074c08a54	10
2475340	norepinephrine (as bitartrate) 8 MG per 250 ML Injection	SY	ddbef60d-c20a-4ada-928f-e87074c08a54	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
44567-640-01	44567064001	250 mL in 1 BAG	250 ml					Historical
44567-640-10	44567064010	10 BAG in 1 CARTON (44567-640-10) / 250 mL in 1 BAG (44567-640-01)	10 bag	2022-10-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE	WG Critical Care, LLC \| Inforlife SA	2026-04-01	HUMAN PRESCRIPTION DRUG LABEL	11